Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells

被引:46
作者
Kraft, HJ
Mosselman, S
Smits, HA
Hohenstein, P
Piek, E
Chen, Q
Artzt, K
vanZoelen, EJJ
机构
[1] UNIV NIJMEGEN,DEPT CELL BIOL,6525 ED NIJMEGEN,NETHERLANDS
[2] UNIV TEXAS,DEPT ZOOL,AUSTIN,TX 78712
关键词
D O I
10.1074/jbc.271.22.12873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of the platelet-derived growth factor alpha-receptor (PDGF alpha R) gene is tightly controlled in mammalian embryogenesis. A well established model system to study human embryogenesis is the embryonal carcinoma cell line Tera2, We have shown previously that retinoic acid-differentiated Tera2 cells express two PDGF alpha R transcripts of 6.4 kilobase pairs (kb) (encoding the full-length receptor) and 3.0 kb, respectively, whereas in contrast, undifferentiated Tera2 cells express PDFG alpha R transcripts of 1.5 kb and 5.0 kb, Here we show that this switch in PDGF alpha R expression pattern during differentiation of Tera2 cells results from alternative promoter use, In undifferentiated cells, a second promoter is used, which is located in intron 12 of the PDGF alpha R gene, Functional analysis shows that this promoter contains a consensus octamer motif, which can be bound by the POU domain transcription factor Oct-4, Oct-4 is expressed in undifferentiated Tera2 cells but not in retinoic acid-induced differentiated cells, Mutation of the octamer motif decreases promoter activity, while ectopic expression of Oct-4 in differentiated Tera2 cells specifically enhances the activity of this PDGF alpha R promoter, Therefore, we suggest that an important aspect in the maintenance of the undifferentiated state of human embryonal carcinoma cells results from Oct-4 expression, which thereupon activates this PDGF alpha R promoter.
引用
收藏
页码:12873 / 12878
页数:6
相关论文
共 39 条
[1]  
AFINK GB, 1995, ONCOGENE, V10, P1667
[2]   HUMAN TERATOCARCINOMAS [J].
ANDREWS, PW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) :17-36
[3]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[4]  
Damjanov I, 1991, Recent Results Cancer Res, V123, P1
[5]   COMPILATION OF VERTEBRATE-ENCODED TRANSCRIPTION FACTORS [J].
FAISST, S ;
MEYER, S .
NUCLEIC ACIDS RESEARCH, 1992, 20 (01) :3-26
[6]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[7]  
HAMPE A, 1989, ONCOGENE RES, V4, P9
[8]   AN OCTAMER MOTIF CONTRIBUTES TO THE EXPRESSION OF THE RETINOIC ACID-REGULATED ZINC FINGER GENE REX-1 (ZFP-42) IN F9 TERATOCARCINOMA CELLS [J].
HOSLER, BA ;
ROGERS, MB ;
KOZAK, CA ;
GUDAS, LJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (05) :2919-2928
[9]   A CHEMILUMINESCENT ASSAY FOR QUANTITATION OF BETA-GALACTOSIDASE IN THE FEMTOGRAM RANGE - APPLICATION TO QUANTITATION OF BETA-GALACTOSIDASE IN IACZ-TRANSFECTED CELLS [J].
JAIN, VK ;
MAGRATH, IT .
ANALYTICAL BIOCHEMISTRY, 1991, 199 (01) :119-124
[10]   FIBROBLAST GROWTH-FACTOR RECEPTOR TYROSINE KINASES - MOLECULAR ANALYSIS AND SIGNAL TRANSDUCTION [J].
JAYE, M ;
SCHLESSINGER, J ;
DIONNE, CA .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1135 (02) :185-199